ACLA Names Sharon West as Vice President, Legal & Regulatory Affairs

September 18, 2017 Categories: ACLA News, All News, Featured News, ACLA Press Releases

Veteran health care leader brings laboratory, legal experience to ACLA

WASHINGTON, D.C. – The American Clinical Laboratory Association (ACLA) announced that Sharon West joins the association today as vice president of legal and regulatory affairs, where she will represent the nation’s leading clinical laboratories on policy matters impacting the industry.

“I am pleased to welcome Sharon to the ACLA team,” said Julie Khani, president of ACLA. “An action-oriented leader with an extensive background in healthcare policy and strategy, Sharon will be a strong asset as we work to advance policies that recognize the value of laboratory testing services and their impact on patient care.”

With a vast career in legal and regulatory analysis, West most recently served as director of economic and regulatory affairs at the College of American Pathologists. She has considerable experience developing effective, evidence-based leadership strategies for stakeholders across the health care sector.

In the years prior, West served as senior corporate counsel for WellCare Health Plans, where she provided strategic counsel on Medicare, Medicaid, and CHIP managed care contract negotiations. She has also managed plan-provider relations for Aetna, NYLCare Health Plans, and Prudential Insurance Company. She holds a law degree from George Mason University School of Law and received her undergraduate degree from Miami University, Oxford, Ohio.

West joins ACLA as Senior Vice President JoAnne Glisson retires at the end of the year.    Glisson’s 21-year tenure at ACLA followed government affairs positions at Stanford University and Kaiser Permanente, as well as professional staff member positions in both the U.S. House of Representatives and the U.S. Senate.

“On behalf of ACLA and its members, I want to thank JoAnne for her commitment to our association and her advocacy on behalf of the laboratory industry,” said Khani.  “She has been instrumental in ACLA’s efforts to advance public policies that promote innovation and protect and enhance patient access to life-saving diagnostics.”

# # #

The ACLA is a not-for-profit association representing the nation’s leading national, regional and esoteric clinical laboratories on key issues of common concern, including federal and state government reimbursement and regulatory policies. 


Print page / Save as PDF